Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
20.19B | 17.46B | 20.78B | 23.60B | 18.52B | 15.67B | Gross Profit |
8.07B | 5.24B | 7.39B | 8.97B | 6.47B | 4.63B | EBIT |
3.68B | 870.00M | 3.21B | 4.95B | 2.66B | 1.01B | EBITDA |
4.68B | 2.11B | 4.31B | 5.97B | 3.59B | 1.65B | Net Income Common Stockholders |
2.70B | 622.00M | 2.61B | 3.80B | 2.04B | 1.08B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
14.25B | 14.25B | 12.81B | 11.82B | 6.66B | 3.88B | Total Assets |
35.08B | 34.77B | 32.69B | 32.99B | 25.58B | 20.65B | Total Debt |
5.66B | 5.66B | 4.18B | 5.19B | 6.46B | 4.73B | Net Debt |
-7.97B | -8.56B | -8.60B | -6.61B | -61.00M | 988.00M | Total Liabilities |
10.41B | 10.10B | 8.45B | 11.20B | 10.17B | 8.55B | Stockholders Equity |
24.67B | 24.67B | 24.24B | 21.79B | 15.41B | 12.10B |
Cash Flow | Free Cash Flow | ||||
0.00 | 397.00M | 2.43B | 3.89B | 19.00M | -1.29B | Operating Cash Flow |
0.00 | 2.31B | 3.35B | 4.81B | 1.42B | 1.53B | Investing Cash Flow |
0.00 | -2.20B | -849.00M | -562.00M | -1.50B | -3.19B | Financing Cash Flow |
0.00 | 879.00M | -1.58B | 947.00M | 2.97B | 1.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $22.50T | 19.52 | 14.32% | 0.52% | 9.56% | 26.52% | |
78 Outperform | $5.08T | 13.13 | 7.87% | 3.08% | 0.24% | 37.62% | |
77 Outperform | ¥2.97T | 17.45 | 1.95% | 4.80% | 34.01% | ||
73 Outperform | $282.01B | 7.40 | 9.28% | 4.21% | 2.73% | ― | |
70 Neutral | $595.80B | 11.03 | 6.70% | 3.79% | 3.72% | 6.31% | |
66 Neutral | ¥26.06B | 7.54 | 3.39% | 15.92% | 227.22% | ||
61 Neutral | $11.29B | 10.07 | -7.05% | 2.96% | 7.47% | -10.75% |